EP News: Case Reports

Left cardiac sympathetic denervation (LCSD) is as an effective treatment for long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and in select cases of substrate-mediated ventricular tachycardia (VT) or fibrillation (VF) in ischemic and nonischemic cardiomyopathy. The use and implications of LCSD on pediatric patients with congenital heart disease are not known. Bonura and colleagues (DOI: https://doi.org/10.1016/j.hrcr.2019.04.007) described two pediatric patients that underwent LCSD in the setting of refractory ventricular arrhythmias and congenital heart disease.

Source: Heart Rhythm - June 10, 2019 Category: Cardiology Authors: T. Jared Bunch Source Type: research